首页> 外文会议>2012 Annual SRII Global Conference. >An Innovative Decision Support Service for Improving Pharmaceutical Acquisition Capabilities
【24h】

An Innovative Decision Support Service for Improving Pharmaceutical Acquisition Capabilities

机译:创新的决策支持服务,可提高药物获取能力

获取原文
获取原文并翻译 | 示例

摘要

The cost of pharmaceutical products is one of the largest contributors of operating costs in providing healthcare services in Thailand. As drug prices change according to shifting market forces, the distribution of purchase prices for each drug varies according to the type of medication and the purchasing power of the healthcare provider. These changes can have significant impact on how well healthcare providers can effectively provide services. PAC-DSS (Pharmaceutical Acquisition Capability Decision Support Service) is an innovative decision support service that enables hospitals to pool together and share information to better understand current market prices and run analytics on drug prices in order to improve their operating costs. Our service allows users to interact with real pricing data to dissect various factors that can contribute to acquisition capabilities of individual drugs such as specific brand names or groups of drugs such as all brands of a given generic drug, without sacrificing individual providers' privacy as we do not disclose individual purchase prices. In developing PAC-DSS, we have had to address a range of technical challenges such as data privacy and alignment of disparate drug ontologies. In this paper, we describe PAC-DSS's service architecture, analytic services, and the benefit of PAC-DSS on improving healthcare services by lowering operating cost without sacrificing service quality. We also discuss the initial benefits from deployment of the service currently hosted by the Ministry of Public Health.
机译:药品成本是泰国提供医疗保健服务的最大运营成本贡献之一。当药品价格根据不断变化的市场力量而变化时,每种药品的购买价格分布会根据药品类型和医疗保健提供者的购买力而变化。这些变化可能会对医疗保健提供者如何有效提供服务产生重大影响。 PAC-DSS(药品获取能力决策支持服务)是一项创新的决策支持服务,使医院可以汇总在一起并共享信息,以更好地了解当前市场价格并对药物价格进行分析,从而提高其运营成本。我们的服务允许用户与真实的价格数据进行交互,以剖析各种因素,这些因素可以提高单个药品的获取能力,例如特定品牌名称或药品组(例如给定仿制药的所有品牌)的获取能力,而不会像我们这样不要透露个人购买价格。在开发PAC-DSS时,我们不得不应对一系列技术挑战,例如数据隐私和不同药物本体的对齐。在本文中,我们描述了PAC-DSS的服务体系结构,分析服务,以及PAC-DSS在不降低服务质量的前提下通过降低运营成本来改善医疗服务的优势。我们还将讨论公共卫生部目前托管的服务部署的初步收益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号